The FDA flagged at least five cases of severe or very severe RSV lower respiratory tract infections in infants immunized with ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...

GSK has terminated a phase 1/2 hepatitis B trial after the therapeutic vaccine regimen failed to meet the efficacy endpoint, denting the company’s hopes of creating a functional cure for the ...

Inequalities in childhood vaccination are widening in England, with uptake rates of five key vaccines consistently lower in young children living in areas of higher deprivation from 2019 to 2023, ...

(Zhifei) to revise the terms on which Zhifei will commercialise GSK’s shingles vaccine, Shingrix, in mainland China. The revised agreement extends the original 3-year period (2024-2026) during which ...

The deal also now includes exclusive rights for China's largest vaccine company to explore a collaboration on GSK's (GSK.L), opens new tab respiratory syncytial virus (RSV) vaccine, Arexvy ...

GSK plc GSK announced that it has revised its collaboration deal with Chongqing Zhifei Biological Products (Zhifei), China's largest vaccine maker, to co-market its shingles vaccine Shingrix in ...